VANCOUVER, B.C./PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company, is pleased to announce that it is receiving advisory services and additional research and development funding of up to CAD$965,000 from the National Research… Read More
SEATTLE, WA– (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the… Read More
EMPOWER Research is gathering information to help guide research towards novel rehabilitation treatments for anxiety, depression, and post-traumatic stress disorder (PTSD) for first responders and military personnel in Canada and… Read More
VICTORIA, BC (NEWS RELEASE) — Douglas magazine is proud to announce this year’s 10 to Watch winners, who represent the very best of Vancouver Island’s new businesses. From identifying faulty… Read More
OTTAWA, ON–(BUSINESS WIRE)–The BIOTECanada Board of Directors is pleased to announce the election of Gordon C. McCauley, President and CEO, AdMare BioInnovations, as Chairman of BIOTECanada at today’s Annual General… Read More
